Kazia Therapeutics Files 6-K Report
Ticker: KZIA · Form: 6-K · Filed: Feb 20, 2025 · CIK: 1075880
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, pharmaceuticals
Related Tickers: KZA
TL;DR
Kazia Therapeutics (KZA) filed a routine 6-K report with the SEC.
AI Summary
Kazia Therapeutics Limited, formerly Novogen Ltd, filed a Form 6-K on February 20, 2025. The company, based in Sydney, NSW, operates in the pharmaceutical preparations sector. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates ongoing regulatory reporting for Kazia Therapeutics, a foreign private issuer, which is standard for companies listed on US exchanges.
Risk Assessment
Risk Level: low — This is a standard regulatory filing for a foreign private issuer and does not contain new material financial or operational information.
Key Numbers
- 000-29962 — SEC File Number (Identifies the specific filing with the SEC)
Key Players & Entities
- Kazia Therapeutics Limited (company) — Registrant
- Novogen Ltd (company) — Former company name
- 000-29962 (dollar_amount) — SEC File Number
- 20250220 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public in its home country, files or makes public with a stock exchange, or distributes or makes public to its security holders.
When was this Form 6-K filed?
This Form 6-K was filed on February 20, 2025.
What is Kazia Therapeutics Limited's principal executive office address?
Kazia Therapeutics Limited's principal executive office is located at Three International Towers Level 24, 300 Barangaroo Avenue, Sydney NSW 2000.
Has Kazia Therapeutics Limited changed its name previously?
Yes, Kazia Therapeutics Limited was formerly known as Novogen Ltd, with a date of name change on December 28, 1998.
What is Kazia Therapeutics Limited's Standard Industrial Classification (SIC) code?
Kazia Therapeutics Limited's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 20, 2025 regarding KAZIA THERAPEUTICS LTD (KZIA).